Mathias B Forrester1. 1. Texas Department of State Health Services, 1100 W. 49th Street, Austin, TX 78756, USA. mathias.forrester@dshs.state.tx.us
Abstract
INTRODUCTION: Dipyrone is an analgesic and antipyretic agent. The purpose of this study was to describe the pattern of dipyrone exposures reported to poison centers. METHODS: Human dipyrone exposures reported to 6 Texas poison centers from 1998 to 2004 were identified. Isolated and non-isolated cases were compared with respect to various factors. RESULTS: When compared to the Census, dipyrone exposures were significantly more likely to have been reported from regions closer to the Mexican border (53% vs 9%). Of 81 dipyrone exposures, 52 (64%) were isolated and 29 (36%) were non-isolated. Most of the dipyrone exposures occurred at the patient's own residence (72/76 or 95%) and the patients were more likely to be female (54/81 or 67%). Although the majority of both types of dipyrone exposures were adults (47/78 or 60%), children, less than 6 years of age, accounted for a higher proportion of isolated exposures (33% vs 10%) while a higher proportion of non-isolated exposures involved older children (28% vs 8%). Twenty-two percent (11/51) of isolated cases were intentional while 59% (17/29) of non-isolated cases were intentional. Of those cases with a known medical outcome, the medical outcome was no adverse clinical effect for 76% (16/21) of isolated exposures and 42% (8/19) of non-isolated exposures. The specific adverse clinical effects reported for isolated exposures were primarily neurological (n = 6), gastrointestinal (n = 4), and dermal (n = 3). The most frequently reported treatment for isolated exposures was some form of decontamination (n = 11). CONCLUSIONS: Isolated and non-isolated dipyrone exposures varied with respect to patient age, exposure reason, management site, medical outcome.
INTRODUCTION:Dipyrone is an analgesic and antipyretic agent. The purpose of this study was to describe the pattern of dipyrone exposures reported to poison centers. METHODS:Humandipyrone exposures reported to 6 Texas poison centers from 1998 to 2004 were identified. Isolated and non-isolated cases were compared with respect to various factors. RESULTS: When compared to the Census, dipyrone exposures were significantly more likely to have been reported from regions closer to the Mexican border (53% vs 9%). Of 81 dipyrone exposures, 52 (64%) were isolated and 29 (36%) were non-isolated. Most of the dipyrone exposures occurred at the patient's own residence (72/76 or 95%) and the patients were more likely to be female (54/81 or 67%). Although the majority of both types of dipyrone exposures were adults (47/78 or 60%), children, less than 6 years of age, accounted for a higher proportion of isolated exposures (33% vs 10%) while a higher proportion of non-isolated exposures involved older children (28% vs 8%). Twenty-two percent (11/51) of isolated cases were intentional while 59% (17/29) of non-isolated cases were intentional. Of those cases with a known medical outcome, the medical outcome was no adverse clinical effect for 76% (16/21) of isolated exposures and 42% (8/19) of non-isolated exposures. The specific adverse clinical effects reported for isolated exposures were primarily neurological (n = 6), gastrointestinal (n = 4), and dermal (n = 3). The most frequently reported treatment for isolated exposures was some form of decontamination (n = 11). CONCLUSIONS: Isolated and non-isolated dipyrone exposures varied with respect to patient age, exposure reason, management site, medical outcome.
Authors: R Abbate; A M Gori; S Pinto; M Attanasio; R Paniccia; M Coppo; S Castellani; B Giusti; M Boddi; G G Neri Serneri Journal: Prostaglandins Leukot Essent Fatty Acids Date: 1990-10 Impact factor: 4.006
Authors: Marcial Sebode; Martin Reike-Kunze; Sören Weidemann; Roman Zenouzi; Johannes Hartl; Moritz Peiseler; Timur Liwinski; Lisa Schulz; Christina Weiler-Normann; Martina Sterneck; Ansgar W Lohse; Christoph Schramm Journal: Br J Clin Pharmacol Date: 2020-03-03 Impact factor: 4.335